1.	Study of Picoplatin Efficacy After Relapse Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 0601, NCT00465491
2.	A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 0502, NCT00448734
3.	A Study of Picoplatin in Colorectal Cancer Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 0501, NCT00478946
4.	Phase II Study of ZD0473 in Patients With Progressive or Relapsed Non-Small Cell Lung Cancer Who Have Failed First-Line Platinum-Based Chemotherapy (Summary Last Modified 09/2001) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UCLA-000307201A, ZENECA-0473IL/0003, NCI-G01-1974, NCT00021008
5.	Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 0402, IND No. 69,507, NCT00116610
6.	Phase I Study of ZD0473 and Doxorubicin HCl Liposome in Patients With Advanced Solid Tumors or Lymphoma (Summary Last Modified 04/2002) Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-00044, NCI-G01-1942, NCT00016172
7.	Cardiac Safety Assessment Study of Picoplatin in Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 0701, NCT00710697